ERK2 Mediates Metabolic Stress Response to Regulate Cell Fate.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 26190261)

Published in Mol Cell on July 16, 2015

Authors

Sejeong Shin1, Gwen R Buel1, Laura Wolgamott2, David R Plas2, John M Asara3, John Blenis4, Sang-Oh Yoon5

Author Affiliations

1: Department of Pharmacology, Meyer Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
2: Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
3: Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA.
4: Department of Pharmacology, Meyer Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: job2064@med.cornell.edu.
5: Department of Pharmacology, Meyer Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: say2008@med.cornell.edu.

Articles cited by this

Upstream and downstream of mTOR. Genes Dev (2004) 21.61

TSC2 mediates cellular energy response to control cell growth and survival. Cell (2003) 20.21

Regulation of cancer cell metabolism. Nat Rev Cancer (2011) 15.44

The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A (2004) 12.30

The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol (2012) 8.52

Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep (2006) 8.16

Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci U S A (1991) 6.79

Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol (2014) 6.25

Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol (2002) 6.05

TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science (2003) 5.25

BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature (2003) 4.80

Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. Mol Cell (2010) 4.07

A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc (2012) 3.87

Epigenetic control of rDNA loci in response to intracellular energy status. Cell (2008) 3.22

Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation (2008) 3.19

Cancer cell metabolism: one hallmark, many faces. Cancer Discov (2012) 3.03

ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events. Mol Cell (2010) 3.03

Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev (2008) 2.28

Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). J Med Chem (2012) 2.21

Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol (2009) 2.01

The proapoptotic function of Noxa in human leukemia cells is regulated by the kinase Cdk5 and by glucose. Mol Cell (2010) 1.95

Hypoglycemia, functional brain failure, and brain death. J Clin Invest (2007) 1.77

Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab (2014) 1.74

Hexokinase-II positively regulates glucose starvation-induced autophagy through TORC1 inhibition. Mol Cell (2014) 1.73

Serine and glycine metabolism in cancer. Trends Biochem Sci (2014) 1.70

Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat Med (2013) 1.62

Glutamine and glutamate--their central role in cell metabolism and function. Cell Biochem Funct (2003) 1.59

Amino acid sensing in dietary-restriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR. Biochem J (2013) 1.46

Mek2 is dispensable for mouse growth and development. Mol Cell Biol (2003) 1.44

Severe hypoglycemia predicts mortality in diabetes. Diabetes Care (2012) 1.31

Metabolic stress in autophagy and cell death pathways. Cold Spring Harb Perspect Biol (2012) 1.30

The UPR and cell fate at a glance. J Cell Sci (2010) 1.30

Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase. Arterioscler Thromb Vasc Biol (2011) 1.20

High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer. Proc Natl Acad Sci U S A (2013) 1.16

Wired on sugar: the role of the CNS in the regulation of glucose homeostasis. Nat Rev Neurosci (2012) 1.10

Methods for detecting autophagy and determining autophagy-induced cell death. Can J Physiol Pharmacol (2010) 1.08

Selective role for Mek1 but not Mek2 in the induction of epidermal neoplasia. Cancer Res (2009) 1.08

PERK utilizes intrinsic lipid kinase activity to generate phosphatidic acid, mediate Akt activation, and promote adipocyte differentiation. Mol Cell Biol (2012) 1.05

Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer. J Clin Invest (2014) 0.98

Vitamin C further improves the protective effect of glucagon-like peptide-1 on acute hypoglycemia-induced oxidative stress, inflammation, and endothelial dysfunction in type 1 diabetes. Diabetes Care (2013) 0.94

Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle. Diabetologia (2011) 0.93

Control of oncogenesis by eIF2α phosphorylation: implications in PTEN and PI3K-Akt signaling and tumor treatment. Future Oncol (2013) 0.91